These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16702733)

  • 1. Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma.
    Nakade S; Ueda S; Ohno T; Nakayama K; Miyata Y; Yukawa E; Higuchi S
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):133-9. PubMed ID: 16702733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics.
    Asano K; Nakade S; Shiomi T; Nakajima T; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Fujita H; Tanigawara Y; Ishizaka A
    Respirology; 2009 Aug; 14(6):822-7. PubMed ID: 19703064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis.
    Sagara H; Yukawa T; Kashima R; Okada T; Fukuda T
    Allergol Int; 2009 Jun; 58(2):277-87. PubMed ID: 19390239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clarithromycin on the pharmacokinetics of pranlukast in healthy volunteers.
    Nakade S; Yamauchi A; Komaba J; Ohno T; Kitagawa J; Honda N; Hasegawa C; Yoneda K; Kodama Y; Yasuda K; Azuma J; Miyata Y
    Drug Metab Pharmacokinet; 2008; 23(6):428-33. PubMed ID: 19122337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effectiveness of the long-term treatment with pranlukast in pediatric patients with mild to moderate asthma].
    Hata D; Shiota M; Tamura Y; Miyazaki M; Ohmura K; Seto S; Furusho K
    Arerugi; 2002 May; 51(5):400-10. PubMed ID: 12087758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers.
    Brocks DR; Upward J; Davy M; Howland K; Compton C; McHugh C; Dennis MJ
    Br J Clin Pharmacol; 1997 Sep; 44(3):289-91. PubMed ID: 9296325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist.
    Grossman J; Faiferman I; Dubb JW; Tompson DJ; Busse W; Bronsky E; Montanaro A; Southern L; Tinkelman D
    J Asthma; 1997; 34(4):321-8. PubMed ID: 9250256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
    Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H
    Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of pranlukast in healthy young and elderly subjects.
    Brocks DR; Upward J; Hust R; Köester FE; Collie H; Qian Y; Dennis MJ
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):375-9. PubMed ID: 8880285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased exhaled nitric oxide in mild persistent asthma patients treated with a leukotriene receptor antagonist, pranlukast.
    Kobayashi H; Takahashi Y; Mitsufuji H; Hataishi R; Cui T; Tanaka N; Kawakami T; Tomita T
    Jpn J Physiol; 1999 Dec; 49(6):541-4. PubMed ID: 10603440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
    Okubo K; Baba K
    Allergol Int; 2008 Dec; 57(4):383-90. PubMed ID: 18946234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketotifen pharmacokinetics in children with atopic perennial asthma.
    McFadyen ML; Miller R; Ludden TM
    Eur J Clin Pharmacol; 1997; 52(5):383-6. PubMed ID: 9272408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
    Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
    Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bronchial hyperreactivity with mannitol dry powder challenge test in a paediatric population with intermittent allergic asthma or allergic rhinitis.
    Decimo F; Capristo C; Amelio R; Maiello N; Capristo AF; Miraglia Del Giudice M
    Int J Immunopathol Pharmacol; 2011; 24(4):1069-74. PubMed ID: 22230412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs.
    Fujita M; Yonetomi Y; Takeda H; Nakagawa N; Kawabata K; Ohno H
    Jpn J Pharmacol; 1997 Dec; 75(4):347-53. PubMed ID: 9469640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.